Clinuvel Pharmaceuticals Ltd (CUV) — Cash Flow Reinvestment Rate
Clinuvel Pharmaceuticals Ltd (CUV) has a Cash Flow Reinvestment Rate of 0.01x as of December 2025, reinvesting AU$149.47K (capex AU$149.47K ) from operating cash flow of AU$12.52 Million. See Clinuvel Pharmaceuticals Ltd (CUV) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Clinuvel Pharmaceuticals Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Clinuvel Pharmaceuticals Ltd across 9 annual periods. For the full cash flow conversion analysis, see Clinuvel Pharmaceuticals Ltd cash flow conversion.
Annual Cash Flow Reinvestment Rate for Clinuvel Pharmaceuticals Ltd (2017–2025)
Year-by-year capital reinvestment analysis for Clinuvel Pharmaceuticals Ltd. See CUV free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.17x | AU$48.01 Million | AU$41.10 Million | AU$298.57K | ▲ +25.1% |
| 2024 | 0.93x | AU$34.61 Million | AU$37.05 Million | AU$5.58 Million | ▲ +1577.7% |
| 2023 | 0.06x | AU$2.06 Million | AU$36.91 Million | AU$1.03 Million | ▲ +155.5% |
| 2022 | 0.02x | AU$868.88K | AU$39.87 Million | AU$434.44K | ▼ -75.4% |
| 2021 | 0.09x | AU$1.71 Million | AU$19.26 Million | AU$854.33K | ▼ -29.2% |
| 2020 | 0.13x | AU$1.78 Million | AU$14.19 Million | AU$888.83K | ▲ +348.8% |
| 2019 | 0.03x | AU$515.23K | AU$18.46 Million | AU$257.62K | ▲ +117.3% |
| 2018 | 0.01x | AU$150.25K | AU$11.69 Million | AU$75.12K | ▼ -5.6% |
| 2017 | 0.01x | AU$134.96K | AU$9.92 Million | AU$67.48K | — |